Results 1 to 10 of about 97,573 (376)

Peripheral B-Cell Immunophenotyping Identifies Heterogeneity in IgG4-Related Disease

Frontiers in Immunology, 2021
ObjectivesTo elucidate heterogeneity of IgG4-related disease (IgG4-RD) based on B cell immunophenotyping.MethodsImmunophenotyping of 4 B-cell subsets in peripheral blood from patients with active IgG4-RD (aIgG4-RD, n=105) was performed using flow ...
Jieqiong Li, Zheng Liu, Panpan Zhang, Wei Lin, Hui Lu, Yu Peng, Linyi Peng, Jiaxin Zhou, Mu Wang, Hua Chen, Lidan Zhao, Li Wang, Chenman Qin, Chaojun Hu, Xiaofeng Zeng, Yan Zhao, Yunyun Fei, Wen Zhang   +17 more
doaj   +2 more sources

Advanced immunophenotyping: A powerful tool for immune profiling, drug screening, and a personalized treatment approach

Frontiers in Immunology, 2023
Various autoimmune diseases are characterized by distinct cell subset distributions and activation profiles of peripheral blood mononuclear cells (PBMCs). PBMCs can therefore serve as an ideal biomarker material, which is easily accessible and allows for
Teresa Preglej, Marie Brinkmann, Günter Steiner, Daniel Aletaha, Lisa Göschl, Michael Bonelli   +5 more
doaj   +2 more sources

EuroFlow: Resetting leukemia and lymphoma immunophenotyping. Basis for companion diagnostics and personalized medicine [PDF]

, 2016
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivative Works 3.0 Unported License.-- Editorial.We are grateful to Dr Jean-Luc Sanne of the European Commission for his support and monitoring of the EuroFlow project.Peer ...
Dongen, J. J. M. van, Orfao, Alberto
core   +3 more sources

T-Cell Subsets Predict Mortality in Malnourished Zambian Adults Initiating Antiretroviral Therapy. [PDF]

, 2015
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are creditedTo estimate the ...
Chisenga, CC, Chisenga, M, Filteau, S, Kelly, P, Prendergast, AJ, Siame, J   +5 more
core   +16 more sources

Carboxypeptidase A3—A Key Component of the Protease Phenotype of Mast Cells

Cells, 2022
Carboxypeptidase A3 (CPA3) is a specific mast cell (MC) protease with variable expression. This protease is one of the preformed components of the secretome.
Dmitri Atiakshin, Andrey Kostin, Ivan Trotsenko, Vera Samoilova, Igor Buchwalow, Markus Tiemann   +5 more
doaj   +1 more source

Mast Cells in Regeneration of the Skin in Burn Wound with Special Emphasis on Molecular Hydrogen Effect

Pharmaceuticals, 2023
The mechanisms of regeneration for the fibrous component of the connective tissue of the dermis are still insufficiently studied. The aim of this study was to evaluate the effectiveness of the use of molecular hydrogen on the local therapy of a II degree
Dmitri Atiakshin, Mariya Soboleva, Dmitry Nikityuk, Nataliya Alexeeva, Svetlana Klochkova, Andrey Kostin, Viktoriya Shishkina, Igor Buchwalow, Markus Tiemann   +8 more
doaj   +1 more source

Immunophenotyping of pulmonary sarcomatoid carcinoma

Frontiers in Immunology, 2022
Background Previous studies have suggested that patients with pulmonary sarcomatoid carcinoma (PSC)may benefit from immune checkpoint inhibitors (ICIs); however, relevant data are lacking.
Yu Ma, Wensheng Li, Zhenzhen Li, Jie-Fu Chen, Hongtao Wang, Tao Jiang, Jianfei Zhu   +6 more
semanticscholar   +1 more source

Mast Cells as a Potential Target of Molecular Hydrogen in Regulating the Local Tissue Microenvironment

Pharmaceuticals, 2023
Knowledge of the biological effects of molecular hydrogen (H2), hydrogen gas, is constantly advancing, giving a reason for the optimism in several healthcare practitioners regarding the management of multiple diseases, including socially significant ones
Dmitri Atiakshin, Andrey Kostin, Artem Volodkin, Anna Nazarova, Viktoriya Shishkina, Dmitry Esaulenko, Igor Buchwalow, Markus Tiemann, Mami Noda   +8 more
doaj   +1 more source

Immunophenotyping assessment in a COVID-19 cohort (IMPACC): A prospective longitudinal study

Science immunology, 2021
IMPACC is a multicenter longitudinal study assessing clinical and immunologic manifestations of COVID-19 in hospitalized patients.
Nadine Rouphael, H. Maecker, Ruth R. Montgomery, J. Diray-Arce, S. Kleinstein, Matthew C. Altman, S. Bosinger, W. Eckalbar, L. Guan, C. Hough, F. Krammer, C. Langelier, Ofer Levy, Kerry McEnaney, B. Peters, Adeeb H. Rahman, J. Rajan, Steve M. Sigelman, H. Steen, H. van Bakel, A. Ward, Michael R. Wilson, P. Woodruff, Colin R. Zamecnik, A. Augustine, A. Ozonoff, Elaine F. Reed, Pat Becker, N. Higuita, M. Atkinson, L. Baden, P. Becker, C. Bime, S. Brakenridge, C. Calfee, Charles B. Cairns, D. Corry, Mark M. Davis, A. Augustine, Lauren I. R. Ehrlich, E. Haddad, D. Erle, A. Fernández-Sesma, D. Hafler, F. Kheradmand, M. Kraft, G. McComsey, E. Melamed, W. Messer, Jordan L. Metcalf, K. Nadeau, B. Pulendran, M. Sarwal, J. Schaenman, R. Sékaly, A. Shaw, V. Simon   +56 more
semanticscholar   +1 more source

Prognostic Immunophenotyping Clusters of Clear Cell Renal Cell Carcinoma Defined by the Unique Tumor Immune Microenvironment

Frontiers in Cell and Developmental Biology, 2021
Background: The tumor microenvironment affects the occurrence and development of cancers, including clear cell renal cell carcinoma (ccRCC). However, how the immune contexture interacts with the cancer phenotype remains unclear.
Wenhao Xu, Aihetaimujiang Anwaier, Chun-guang Ma, Wangrui Liu, X. Tian, Jia-Qi Su, Wenkai Zhu, Guohai Shi, Shiyin Wei, Hong Xu, Y. Qu, D. Ye, Hailiang Zhang   +12 more
semanticscholar   +1 more source